CEL-SCI Corporation (CVM)
USD 0.3
(43.2%)
USD 0.3
(43.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 30.52 Million USD | -39.58% |
| 2022 | 50.52 Million USD | -33.41% |
| 2021 | 75.86 Million USD | 87.16% |
| 2020 | 40.53 Million USD | 46.75% |
| 2019 | 27.62 Million USD | -6.64% |
| 2018 | 29.58 Million USD | 29.06% |
| 2017 | 22.92 Million USD | 97.65% |
| 2016 | 11.59 Million USD | -24.92% |
| 2015 | 15.44 Million USD | -19.67% |
| 2014 | 19.23 Million USD | 77.43% |
| 2013 | 10.83 Million USD | -32.54% |
| 2012 | 16.06 Million USD | -13.73% |
| 2011 | 18.62 Million USD | -50.73% |
| 2010 | 37.8 Million USD | -17.86% |
| 2009 | 46.02 Million USD | 213.46% |
| 2008 | 14.68 Million USD | -29.17% |
| 2007 | 20.73 Million USD | 114.75% |
| 2006 | 9.65 Million USD | 212.17% |
| 2005 | 3.09 Million USD | -43.92% |
| 2004 | 5.51 Million USD | 89.14% |
| 2003 | 2.91 Million USD | -22.7% |
| 2002 | 3.77 Million USD | -16.36% |
| 2001 | 4.5 Million USD | -67.35% |
| 2000 | 13.8 Million USD | 81.7% |
| 1999 | 7.6 Million USD | -47.22% |
| 1998 | 14.4 Million USD | 128.57% |
| 1997 | 6.3 Million USD | -47.06% |
| 1996 | 11.9 Million USD | 85.94% |
| 1995 | 6.4 Million USD | -20.99% |
| 1994 | 8.1 Million USD | -30.17% |
| 1993 | 11.6 Million USD | -15.94% |
| 1992 | 13.8 Million USD | 762.5% |
| 1991 | 1.6 Million USD | 220.0% |
| 1990 | 500 Thousand USD | 0.0% |
| 1989 | 500 Thousand USD | -16.67% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 24.06 Million USD | -19.9% |
| 2024 Q2 | 30.04 Million USD | 4.66% |
| 2024 Q1 | 28.71 Million USD | -5.96% |
| 2023 Q3 | 32.31 Million USD | -15.38% |
| 2023 Q1 | 44.55 Million USD | -11.81% |
| 2023 Q2 | 38.19 Million USD | -14.28% |
| 2023 FY | 30.52 Million USD | -39.58% |
| 2023 Q4 | 30.52 Million USD | -5.54% |
| 2022 Q1 | 69.67 Million USD | -8.17% |
| 2022 Q4 | 50.52 Million USD | -11.19% |
| 2022 Q3 | 56.88 Million USD | -11.33% |
| 2022 Q2 | 64.16 Million USD | -7.91% |
| 2022 FY | 50.52 Million USD | -33.41% |
| 2021 Q4 | 75.86 Million USD | -4.74% |
| 2021 Q3 | 79.64 Million USD | 64.67% |
| 2021 Q2 | 48.36 Million USD | -2.52% |
| 2021 Q1 | 49.61 Million USD | 22.39% |
| 2021 FY | 75.86 Million USD | 87.16% |
| 2020 Q3 | 42.03 Million USD | 21.08% |
| 2020 FY | 40.53 Million USD | 46.75% |
| 2020 Q1 | 29.5 Million USD | 6.82% |
| 2020 Q2 | 34.71 Million USD | 17.65% |
| 2020 Q4 | 40.53 Million USD | -3.56% |
| 2019 Q2 | 24.75 Million USD | -4.54% |
| 2019 FY | 27.62 Million USD | -6.64% |
| 2019 Q4 | 27.62 Million USD | -3.02% |
| 2019 Q3 | 28.48 Million USD | 15.07% |
| 2019 Q1 | 25.93 Million USD | -12.35% |
| 2018 Q1 | 22.17 Million USD | -3.27% |
| 2018 FY | 29.58 Million USD | 29.06% |
| 2018 Q4 | 29.58 Million USD | 36.34% |
| 2018 Q3 | 21.7 Million USD | -6.02% |
| 2018 Q2 | 23.09 Million USD | 4.13% |
| 2017 Q2 | 8.72 Million USD | -12.11% |
| 2017 FY | 22.92 Million USD | 97.65% |
| 2017 Q4 | 22.92 Million USD | 171.7% |
| 2017 Q3 | 8.43 Million USD | -3.31% |
| 2017 Q1 | 9.92 Million USD | -14.4% |
| 2016 FY | 11.59 Million USD | -24.92% |
| 2016 Q1 | 19.98 Million USD | 29.37% |
| 2016 Q2 | 15.51 Million USD | -22.35% |
| 2016 Q3 | 14.48 Million USD | -6.69% |
| 2016 Q4 | 11.59 Million USD | -19.91% |
| 2015 Q2 | 12.72 Million USD | -34.92% |
| 2015 Q4 | 15.44 Million USD | -28.14% |
| 2015 Q3 | 21.49 Million USD | 68.91% |
| 2015 Q1 | 19.55 Million USD | 1.68% |
| 2015 FY | 15.44 Million USD | -19.67% |
| 2014 Q1 | 24.79 Million USD | 128.8% |
| 2014 Q2 | 21.81 Million USD | -12.01% |
| 2014 FY | 19.23 Million USD | 77.43% |
| 2014 Q4 | 19.23 Million USD | -23.56% |
| 2014 Q3 | 25.15 Million USD | 15.31% |
| 2013 Q1 | 22.01 Million USD | 37.0% |
| 2013 Q4 | 10.83 Million USD | -26.52% |
| 2013 Q3 | 14.75 Million USD | -20.23% |
| 2013 Q2 | 18.49 Million USD | -16.0% |
| 2013 FY | 10.83 Million USD | -32.54% |
| 2012 Q4 | 16.06 Million USD | -19.36% |
| 2012 Q2 | 18.38 Million USD | 10.23% |
| 2012 Q1 | 16.67 Million USD | -10.45% |
| 2012 FY | 16.06 Million USD | -13.73% |
| 2012 Q3 | 19.92 Million USD | 8.39% |
| 2011 FY | 18.62 Million USD | -50.73% |
| 2011 Q4 | 18.62 Million USD | -21.55% |
| 2011 Q3 | 23.74 Million USD | -22.84% |
| 2011 Q2 | 30.77 Million USD | -9.93% |
| 2011 Q1 | 34.16 Million USD | -9.63% |
| 2010 Q3 | 42.1 Million USD | -6.48% |
| 2010 Q4 | 37.8 Million USD | -10.22% |
| 2010 FY | 37.8 Million USD | -17.86% |
| 2010 Q2 | 45.02 Million USD | -7.17% |
| 2010 Q1 | 48.5 Million USD | 5.38% |
| 2009 Q3 | 18.54 Million USD | 30.1% |
| 2009 Q1 | 13.68 Million USD | -6.83% |
| 2009 Q2 | 14.25 Million USD | 4.19% |
| 2009 Q4 | 46.02 Million USD | 148.22% |
| 2009 FY | 46.02 Million USD | 213.46% |
| 2008 Q1 | 19.05 Million USD | -8.1% |
| 2008 Q2 | 17.65 Million USD | -7.36% |
| 2008 Q3 | 15.21 Million USD | -13.79% |
| 2008 Q4 | 14.68 Million USD | -3.5% |
| 2008 FY | 14.68 Million USD | -29.17% |
| 2007 Q1 | 8.43 Million USD | -12.63% |
| 2007 Q2 | 7.08 Million USD | -16.01% |
| 2007 FY | 20.73 Million USD | 114.75% |
| 2007 Q4 | 20.73 Million USD | 0.42% |
| 2007 Q3 | 20.64 Million USD | 191.44% |
| 2006 FY | 9.65 Million USD | 212.17% |
| 2006 Q2 | 2.87 Million USD | -3.51% |
| 2006 Q4 | 9.65 Million USD | 253.85% |
| 2006 Q3 | 2.72 Million USD | -4.99% |
| 2006 Q1 | 2.97 Million USD | -3.76% |
| 2005 Q2 | 3.35 Million USD | -25.13% |
| 2005 Q4 | 3.09 Million USD | 18.88% |
| 2005 FY | 3.09 Million USD | -43.92% |
| 2005 Q1 | 4.47 Million USD | -18.85% |
| 2005 Q3 | 2.6 Million USD | -22.36% |
| 2004 Q3 | 6.56 Million USD | 115.11% |
| 2004 Q4 | 5.51 Million USD | -16.06% |
| 2004 FY | 5.51 Million USD | 89.14% |
| 2004 Q2 | 3.05 Million USD | -13.12% |
| 2004 Q1 | 3.51 Million USD | 20.56% |
| 2003 Q2 | 2.9 Million USD | -3.03% |
| 2003 Q1 | 2.99 Million USD | -20.7% |
| 2003 FY | 2.91 Million USD | -22.7% |
| 2003 Q4 | 2.91 Million USD | -3.11% |
| 2003 Q3 | 3 Million USD | 3.75% |
| 2002 Q3 | 3.35 Million USD | -15.2% |
| 2002 Q1 | 4.92 Million USD | 9.13% |
| 2002 Q4 | 3.77 Million USD | 12.37% |
| 2002 Q2 | 3.95 Million USD | -19.56% |
| 2002 FY | 3.77 Million USD | -16.36% |
| 2001 Q1 | 11.26 Million USD | -18.43% |
| 2001 Q4 | 4.5 Million USD | -14.43% |
| 2001 Q3 | 5.26 Million USD | -28.14% |
| 2001 FY | 4.5 Million USD | -67.35% |
| 2001 Q2 | 7.33 Million USD | -34.89% |
| 2000 Q4 | 13.8 Million USD | -9.19% |
| 2000 Q1 | 8.1 Million USD | 6.58% |
| 2000 Q3 | 15.2 Million USD | -12.58% |
| 2000 FY | 13.8 Million USD | 81.7% |
| 2000 Q2 | 17.39 Million USD | 114.76% |
| 1999 Q4 | 7.6 Million USD | -14.61% |
| 1999 Q3 | 8.9 Million USD | -17.59% |
| 1999 Q2 | 10.8 Million USD | -14.96% |
| 1999 FY | 7.6 Million USD | -47.22% |
| 1999 Q1 | 12.7 Million USD | -11.81% |
| 1998 FY | 14.4 Million USD | 128.57% |
| 1998 Q4 | 14.4 Million USD | -8.86% |
| 1998 Q3 | 15.8 Million USD | -8.14% |
| 1998 Q2 | 17.2 Million USD | -1.15% |
| 1998 Q1 | 17.4 Million USD | 176.19% |
| 1997 Q3 | 7.7 Million USD | -14.44% |
| 1997 Q1 | 11 Million USD | -7.56% |
| 1997 FY | 6.3 Million USD | -47.06% |
| 1997 Q4 | 6.3 Million USD | -18.18% |
| 1997 Q2 | 9 Million USD | -18.18% |
| 1996 FY | 11.9 Million USD | 85.94% |
| 1996 Q2 | 5.9 Million USD | 15.69% |
| 1996 Q3 | 8.7 Million USD | 47.46% |
| 1996 Q4 | 11.9 Million USD | 36.78% |
| 1996 Q1 | 5.1 Million USD | -20.31% |
| 1995 FY | 6.4 Million USD | -20.99% |
| 1995 Q3 | 6.2 Million USD | 3.33% |
| 1995 Q1 | 6.8 Million USD | -16.05% |
| 1995 Q2 | 6 Million USD | -11.76% |
| 1995 Q4 | 6.4 Million USD | 3.23% |
| 1994 FY | 8.1 Million USD | -30.17% |
| 1994 Q4 | 8.1 Million USD | -5.81% |
| 1994 Q3 | 8.6 Million USD | -11.34% |
| 1994 Q2 | 9.7 Million USD | -11.01% |
| 1994 Q1 | 10.9 Million USD | -6.03% |
| 1993 Q3 | 12.3 Million USD | -3.91% |
| 1993 Q4 | 11.6 Million USD | -5.69% |
| 1993 FY | 11.6 Million USD | -15.94% |
| 1993 Q1 | 13.4 Million USD | -2.9% |
| 1993 Q2 | 12.8 Million USD | -4.48% |
| 1992 Q1 | 1.1 Million USD | -31.25% |
| 1992 Q2 | 14.5 Million USD | 1218.18% |
| 1992 Q3 | 14.2 Million USD | -2.07% |
| 1992 Q4 | 13.8 Million USD | -2.82% |
| 1992 FY | 13.8 Million USD | 762.5% |
| 1991 FY | 1.6 Million USD | 220.0% |
| 1991 Q4 | 1.6 Million USD | 77.78% |
| 1991 Q2 | 1 Million USD | 11.11% |
| 1991 Q3 | 900 Thousand USD | -10.0% |
| 1991 Q1 | 900 Thousand USD | 80.0% |
| 1990 Q2 | 800 Thousand USD | 14.29% |
| 1990 Q4 | 500 Thousand USD | -44.44% |
| 1990 FY | 500 Thousand USD | 0.0% |
| 1990 Q1 | 700 Thousand USD | 40.0% |
| 1990 Q3 | 900 Thousand USD | 12.5% |
| 1989 Q3 | 800 Thousand USD | 0.0% |
| 1989 Q4 | 500 Thousand USD | -37.5% |
| 1989 FY | 500 Thousand USD | -16.67% |
| 1989 Q1 | 800 Thousand USD | 33.33% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 19.38 Million USD | -57.516% |
| Ampio Pharmaceuticals, Inc. | 5.73 Million USD | -432.222% |
| Armata Pharmaceuticals, Inc. | 109.96 Million USD | 72.238% |
| Actinium Pharmaceuticals, Inc. | 81.44 Million USD | 62.517% |
| Azitra, Inc. | 5.11 Million USD | -496.781% |
| Can-Fite BioPharma Ltd. | 9.98 Million USD | -205.619% |
| Chromocell Therapeutics Corporation | 96.39 Thousand USD | -31571.266% |
| Calidi Biotherapeutics, Inc. | 10.01 Million USD | -204.704% |
| iBio, Inc. | 28.73 Million USD | -6.244% |
| Lineage Cell Therapeutics, Inc. | 101.01 Million USD | 69.78% |
| MAIA Biotechnology, Inc. | 7.56 Million USD | -303.447% |
| Matinas BioPharma Holdings, Inc. | 65.57 Million USD | 53.447% |
| Navidea Biopharmaceuticals, Inc. | 4.37 Million USD | -598.33% |
| NovaBay Pharmaceuticals, Inc. | 9.03 Million USD | -237.926% |
| NanoViricides, Inc. | 12.82 Million USD | -138.077% |
| Oragenics, Inc. | 4.96 Million USD | -514.704% |
| BiomX Inc. | 58.15 Million USD | 47.506% |
| BiomX Inc. | 58.15 Million USD | 47.506% |
| Protalix BioTherapeutics, Inc. | 84.43 Million USD | 63.844% |
| Palatin Technologies, Inc. | 10.74 Million USD | -184.188% |
| Scorpius Holdings, Inc. | 51.03 Million USD | 40.185% |
| Theriva Biologics, Inc. | 60.21 Million USD | 49.298% |